Novartis India Ltd vs Pentokey Organy India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Novartis India Ltd is ₹ 1180 as of 18 May 15:30 . The P/E Ratio of Novartis India Ltd changed from 65.2 on March 2021 to 19.2 on March 2025 . This represents a CAGR of -21.69% over 5 yearsThe P/E Ratio of Pentokey Organy (India) Ltd changed from 8.2 on March 2023 to 81.2 on March 2025 . This represents a CAGR of 114.74% over 3 years The Market Cap of Novartis India Ltd changed from ₹ 1362 crore on March 2021 to ₹ 1938 crore on March 2025 . This represents a CAGR of 7.30% over 5 yearsThe Market Cap of Pentokey Organy (India) Ltd changed from ₹ 6.83 crore on March 2021 to ₹ 19.84 crore on March 2025 . This represents a CAGR of 23.77% over 5 years The revenue of Novartis India Ltd for the Mar '26 is ₹ 100.56 crore as compare to the Dec '25 revenue of ₹ 94.65 crore. This represent the growth of 6.24% The revenue of Pentokey Organy (India) Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ -2.01 crore. This represent the decline of -100% The ebitda of Novartis India Ltd for the Mar '26 is ₹ 30.63 crore as compare to the Dec '25 ebitda of ₹ 31.11 crore. This represent the decline of -1.54% The ebitda of Pentokey Organy (India) Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -0.29 crore. This represent the decline of -100% The net profit of Novartis India Ltd changed from ₹ 25.74 crore to ₹ 25.25 crore over 8 quarters. This represents a CAGR of -0.96% The net profit of Pentokey Organy (India) Ltd changed from ₹ 0.05 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Novartis India Ltd changed from 118.09 % on March 2021 to 61.15 % on March 2025 . This represents a CAGR of -12.33% over 5 yearsThe Dividend Payout of Pentokey Organy (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

About Pentokey Organy (India) Ltd

Pentokey Organy (India) Limited was incorporated on November 26, 1986.
The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde.
Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc. In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices.
Company therefore purchased the Acetic Acid from market instead of producing the same from Ethanol or Acetaldehyde.
As a result of this, production of Acetaldehyde, which is an intermediate product for Acetic Acid, was low.

FAQs for the comparison of Novartis India Ltd and Pentokey Organy (India) Ltd

Which company has a larger market capitalization, Novartis India Ltd or Pentokey Organy (India) Ltd?

Market cap of Novartis India Ltd is 2,914 Cr while Market cap of Pentokey Organy (India) Ltd is 26 Cr

What are the key factors driving the stock performance of Novartis India Ltd and Pentokey Organy (India) Ltd?

The stock performance of Novartis India Ltd and Pentokey Organy (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novartis India Ltd and Pentokey Organy (India) Ltd?

As of May 18, 2026, the Novartis India Ltd stock price is INR ₹1180.5. On the other hand, Pentokey Organy (India) Ltd stock price is INR ₹42.4.

How do dividend payouts of Novartis India Ltd and Pentokey Organy (India) Ltd compare?

To compare the dividend payouts of Novartis India Ltd and Pentokey Organy (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.